Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GLAXF - Adaptimmune Therapeutics: A Little More Patience May Be Profitable

GLAXF - Adaptimmune Therapeutics: A Little More Patience May Be Profitable

GlaxoSmithKline Plc
  • I must say up front that I do not expect ADAP to make me a profit in the next 12 months because of the poor market conditions.
  • However, I still like the science and am holding on to a small position for the longer term.
  • ADAP has a BLA filing in 2022.

For further details see:

Adaptimmune Therapeutics: A Little More Patience May Be Profitable
Stock Information
Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com
Menu
GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...